From September 11 to September 14, the Urological Minimally Invasive Diagnosis and Treatment Training Program, initiated by Beijing Hospital, was successfully held in Beijing. The event brought together urology specialists and international distributors from leading hospitals worldwide to exchange insights on the latest applications of minimally invasive urological technologies. On September 12, Professor Meng Yisen from the Department of Urology at Peking University First Hospital delivered a keynote presentation, offering an in-depth overview of the technological breakthroughs and clinical value of the domestically developed metaFlow® Image-Guided Robotic System in the treatment of benign prostatic hyperplasia (BPH).

Addressing Clinical Needs: The Innovation Behind Robotic System Technology
As a leading expert in minimally invasive urology in China, Professor Meng Yisen drew upon his extensive clinical experience to systematically examine the limitations of conventional BPH surgical procedures and the transformative impact of Robotic System technology. He noted that while existing surgical approaches are widely used in clinical practice, they often require trade-offs between preserving patient function and achieving long-term durability. The metaFlow® Robotic System, through its unique combination of image guidance and athermal tissue resection, directly addresses this long-standing clinical challenge.
As a participant in multicenter clinical studies, Professor Meng presented clinical outcomes from Peking University First Hospital, demonstrating the significant advantages of the Robotic System in clinical practice. Patients experienced substantial improvements in urinary function after surgery, while urinary continence and sexual function were effectively preserved. These benefits make the technology particularly suitable for elderly patients who require higher standards of surgical safety. He emphasized that through precise tissue resection and its minimally invasive nature, the technology significantly reduces the risk of complications commonly associated with traditional procedures, relieving obstruction while preserving normal prostate function.

Global Perspective: International Interest and Cross-Border Clinical Dialogue
Participants in the training program came primarily from countries along the Belt and Road Initiative, including Indonesia, Malaysia, Nepal, the Philippines, Qatar, Saudi Arabia, Tajikistan, Thailand, and Vietnam. Healthcare professionals from these nations gathered to learn about and discuss China's most advanced innovations in urological care. Participants actively engaged in discussions regarding the practical application of the metaFlow® Robotic System, demonstrating strong interest in its technological features and clinical benefits.

With its core advantages of athermal treatment, functional preservation, and rapid recovery, the metaFlow® Robotic System is steadily gaining recognition among healthcare professionals both in China and internationally.
In its international expansion efforts, Healinno Tech remains committed to an open and collaborative approach. The company is currently developing preliminary partnership initiatives with multiple countries and regions, with plans to introduce Robotic System technology to broader global markets.
Looking ahead, Healinno Tech will continue to participate in global exchanges within the field of minimally invasive medicine, enabling international peers to experience firsthand the clinical value of innovative technologies. Through these efforts, the company aims to contribute to the advancement of urological innovation worldwide and improve outcomes for patients around the globe.
metaFlow
Image-guided
Precise, robotic execution
Heat-free resection and removal
Waterjet Surgical Robot
Multi-dimensional surgical planning
Robotic execution
Precise waterjet control
About Us
Company Profile
Contact Us
News
Contact Us
Address:Room 501, Building No. 2, No.1 Courtyard Disheng East Road, BDA, 100176 Beijing, China
Tel:+86 10 87160915
Email:service@healinno.cn